TABLE 2.
Sample origin | In vitro model | Observation(s) | Implication(s) | Sampling time frame | Subtype selectivity | References | |
fSZ/sSZ | Fibroblasts | iPSC, differentiated to neural progenitor cells | Abnormal gene and protein levels related to cytoskeletal remodeling and increased oxidative stress | SZ hiPSC NPCs may serve as a proxy for the developmental pathways potentially contributing to SZ pathogenesis | Late-stage | None | Brennand et al., 2015 |
Fibroblasts | iPSC, differentiated to CA3 neurons and DG neurons | Reduction of activity in DG-CA3 co-culture and deficits in spontaneous and evoked activity in CA3 neurons | iPSC-derived CA3 neurons and DG neurons may recapitulate SZ hippocampal activity | Late-stage | None | Sarkar et al., 2018 | |
Fibroblasts | iPSC, differentiated to neural progenitor cells, glutamatergic neurons | Reduced number of neurite and protein level of PSD95 | Report decreased neuronal connectivity, synaptic protein level and glutamate receptor expression in SZ iPSC neurons | Late-stage | None | Brennand et al., 2011 | |
Fibroblasts | iPSC, differentiated to dentate gyrus granule neurons | Reduced hippocampal neurogenesis and attenuated spontaneous neurotransmitter release | iPSC-derived DG granule neurons recapitulate SZ hippocampal neurogenesis features including lowered level of NEUROD1, PROX1 and TBR1 | Late-stage | None | Yu et al., 2014 | |
Fibroblasts | iPSC, differentiated to forebrain mixed neurons | Increase of gene expression of WNT signaling genes and β-catenin protein levels | Abnormal expression of WNT signaling proteins may underlie SZ | Late-stage | None | Topol et al., 2015 | |
Fibroblasts | iPSC-derived cerebral organoids | Altered distribution of cortical neurons in correlation with abnormal expression of nuclear FGFR1 in neuronal committed cells | Altered FGFR1 signaling is linked to cortical malformation in SZ patient-derived cerebral organoid models | Late-stage | None | Stachowiak et al., 2017 | |
Fibroblasts | iPSC-derived cerebral organoids | Increased production of malformative TNF and increased developmental vulnerability to TNF | Development of brain pathology in SZ is exacerbated by abnormal TNF expression | Late-stage | None | Benson et al., 2020 | |
fSZ | Fibroblasts | iPSC, differentiated to neural progenitor cells | Reduced protein level of CYFIP1 and WAVE | 15q11.2 microdeletion affects neural developmental processes by altering CYFIP1 signaling and WAVE complex signaling | Childhood-onset SZ | 15q11.2 deletion | Yoon et al., 2014 |
Fibroblasts | iPSC, differentiated to neurons, neural progenitor cells and oligodendrocyte precursor cells | Decreased expression of exon14-15 of CNTNAP2 and reduced neural migration | Present that both exon-and allele-specific expression of CNTNAP2 may be critical for the predisposition of SZ | Late-stage | Large heterozygous CNTNAP2 deletion | Lee et al., 2015 | |
Hair follicle keratinocytes | iPSC, differentiated to dopaminergic neurons and glutamatergic neurons | Morphological abnormalities of dopaminergic neurons and mitochondrial dysfunction in keratinocytes | Unravel impaired ability to differentiate into dopaminergic neurons and mitochondrial dysfunction including abnormal mitochondrial membrane potential, trafficking and turnover in SZ | Late-stage | Paranoid SZ | Robicsek et al., 2013 | |
Fibroblasts | iPSC, differentiated to neural progenitor cells | Downregulation of miR-9 in correlation with reduced migration in neural progenitor cells | miR-9 as a risk factor for SZ | Late-stage and childhood-onset SZ | None | Topol et al., 2016 | |
sSZ | Fibroblasts | iPSC, differentiated to glutamatergic and GABAergic neurons | Reduced expression of almost all genes in the 22q11.2 region | Identified potential druggable targets in neuropsychiatric diseases associated with 22q11.2 del | Late-stage | 22q11.2 deletion | Lin et al., 2016 |
Fibroblasts | iPSC, differentiated to neural progenitor cells and neurospheres | Reduced expression level of miRNAs belonging to miR-17/92 cluster and miR-106a/b and upregulated p38α | Potential novel p38α-targeting therapeutics for SZ | Late-stage | 22q11.2 deletion | Toyoshima et al., 2016 | |
Fibroblasts | iPSC, differentiated to mixed neurons | Dysregulated expression of miRNAs | Suggest that iPSCs derived from patient with 22q11.2 del SZ may be utilized to study the disease | Late-stage and childhood-onset SZ | 22q11.2 deletion | Zhao et al., 2015 | |
Fibroblasts | iPSC, differentiation to forebrain mixed neurons and MAP2AB + neurons | Reduced wild-type DISC1 protein level and synaptic vesicle release | Mutant DISC1 depletes wild-type DISC1 protein and causes synaptic abnormalities including defects in glutamatergic synaptic transmission and synapse formation | Late-stage | DISC1 4-bp deletion | Wen et al., 2014 | |
Fibroblasts | iPSC, differentiated to neural precursor cells | Increase of extramitochondrial oxygen consumption and ROS level | Abnormal metabolic changes during neurogenesis is associated with SZ | Late-stage | Clozapine resistant patient | Paulsen Bda et al., 2012 |
fSZ, familial schizophrenia; sSZ, sporadic schizophrenia; DG, dentate gyrus; TNF, tumor necrosis factor; ROS, reactive oxygen species.